PT690132E - Anticorpo monoclonal anti-hiv - Google Patents

Anticorpo monoclonal anti-hiv

Info

Publication number
PT690132E
PT690132E PT94909286T PT94909286T PT690132E PT 690132 E PT690132 E PT 690132E PT 94909286 T PT94909286 T PT 94909286T PT 94909286 T PT94909286 T PT 94909286T PT 690132 E PT690132 E PT 690132E
Authority
PT
Portugal
Prior art keywords
region
antibody
hiv
monoclonal antibody
pnd
Prior art date
Application number
PT94909286T
Other languages
English (en)
Inventor
Yasuyuki Eda
Kouichi Shiosaki
Sachio Tokiyoshi
Kazuhiko Kimachi
Hiroaki Maeda
Keiichi Makizumi
Kiyoshi Osatomi
Hirofumi Higuchi
Original Assignee
Juridical Fou The Chemo Sero T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juridical Fou The Chemo Sero T filed Critical Juridical Fou The Chemo Sero T
Publication of PT690132E publication Critical patent/PT690132E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT94909286T 1993-03-11 1994-03-09 Anticorpo monoclonal anti-hiv PT690132E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7891393 1993-03-11

Publications (1)

Publication Number Publication Date
PT690132E true PT690132E (pt) 2004-04-30

Family

ID=13675093

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94909286T PT690132E (pt) 1993-03-11 1994-03-09 Anticorpo monoclonal anti-hiv

Country Status (11)

Country Link
US (1) US6114143A (pt)
EP (1) EP0690132B1 (pt)
JP (1) JP3855071B2 (pt)
KR (1) KR100337069B1 (pt)
AT (1) ATE256751T1 (pt)
AU (1) AU681633B2 (pt)
DE (1) DE69433422T2 (pt)
DK (1) DK0690132T3 (pt)
ES (1) ES2213148T3 (pt)
PT (1) PT690132E (pt)
WO (1) WO1994020632A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443330A1 (en) * 2001-04-05 2002-10-17 Toshimitsu Uede Anti-osteopontin antibody and use thereof
KR100423614B1 (ko) * 2001-05-16 2004-03-22 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
KR20040048899A (ko) 2001-09-25 2004-06-10 가부시키가이샤 멘에키세이부츠 켄큐죠 재조합 항-오스테오폰틴 항체 및 그의 용도
US7153509B2 (en) 2001-11-07 2006-12-26 Duke University Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
US7172761B2 (en) * 2001-11-07 2007-02-06 Duke University Polyvalent immunogen
US7195768B2 (en) * 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
US7041499B2 (en) * 2001-12-12 2006-05-09 University Of North Texas Health Science Center Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
CN1659225B (zh) * 2002-04-12 2012-06-27 Mba聚合物公司 包含回收塑料的组合物
AU2003241103A1 (en) * 2002-04-23 2003-11-10 Umberto Dianzani Compositions containing anti-hiv peptides and methods of use
US8332159B2 (en) * 2003-02-20 2012-12-11 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method for enhancing efficacy of preparation of monoclonal antibody
US20050014230A1 (en) * 2003-07-16 2005-01-20 Ccl Holding Co., Ltd. Preparation of fully human antibodies
US7807157B2 (en) 2004-02-20 2010-10-05 Intellect Neurosciences Inc. Monoclonal antibodies and use thereof
JP2009509970A (ja) * 2005-09-22 2009-03-12 プロサイ インコーポレイテッド 酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法
KR20090024748A (ko) 2006-05-31 2009-03-09 아스텔라스세이야쿠 가부시키가이샤 인간화 항인간 오스테오폰틴 항체
JP5440179B2 (ja) 2008-01-11 2014-03-12 アステラス製薬株式会社 改良型ヒト化抗ヒトα９インテグリン抗体
US20110300068A1 (en) 2009-01-12 2011-12-08 Takeda Pharmaceutical Company Limited Agent for prophylaxis or treatment of cancer
JP5726165B2 (ja) 2010-03-11 2015-05-27 株式会社 資生堂 アオウキクサ由来の新規リポキシゲナーゼ
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
JP5726172B2 (ja) 2010-03-31 2015-05-27 株式会社 資生堂 アオウキクサ由来の新規アレンオキサイドシンターゼ
TW201249867A (en) 2011-04-01 2012-12-16 Astellas Pharma Inc Novel anti-human il-23 receptor antibody
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ME02944B (me) 2011-08-11 2018-04-20 Astellas Pharma Inc Novo antitelo protiv humanog ngf
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
AR089425A1 (es) 2011-12-22 2014-08-20 Astellas Pharma Inc Anticuerpo ctgf (factor de crecimiento de tejido conectivo) antihumano
US9371391B2 (en) 2012-02-28 2016-06-21 Astellas Pharma Inc. Anti-human IL-23 receptor antibody and encoding polynucleotides
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
SG11201600935SA (en) 2013-08-09 2016-03-30 Astellas Pharma Inc Novel anti-human tslp receptor antibody
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3088519A4 (en) 2013-12-24 2017-09-13 Astellas Pharma Inc. Novel anti-human bdca-2 antibody
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
CA3102859A1 (en) 2018-07-03 2020-01-09 Gilead Sciences, Inc. Antibodies that target hiv gp120 and methods of use
JP2021534093A (ja) 2018-08-20 2021-12-09 江蘇恒瑞医薬股▲ふん▼有限公司 腫瘍処置用医薬の製造におけるｔｉｍ−３抗体の使用
US20220002389A1 (en) * 2018-10-29 2022-01-06 Immuno-Biological Laboratories Co., Ltd. Anti-hiv antibody and method for producing same
IL282650B1 (en) 2018-10-31 2024-05-01 Astellas Pharma Inc Anti-human FN14 antibody

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0436634A1 (en) * 1988-10-03 1991-07-17 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
WO1990015078A1 (en) * 1989-06-05 1990-12-13 Scott Charles F Jr HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120
RU2128222C1 (ru) * 1991-08-22 1999-03-27 Ниссин Сокухин Кабусики Кайся Мышиное моноклональное антитело nm01, гибридомная клеточная линия, фрагмент мышиного могоклонального антитела (варианты)

Also Published As

Publication number Publication date
AU681633B2 (en) 1997-09-04
WO1994020632A1 (en) 1994-09-15
DE69433422D1 (de) 2004-01-29
KR960701214A (ko) 1996-02-24
ATE256751T1 (de) 2004-01-15
EP0690132B1 (en) 2003-12-17
KR100337069B1 (ko) 2002-10-11
DK0690132T3 (da) 2004-04-13
EP0690132A1 (en) 1996-01-03
EP0690132A4 (en) 1998-07-29
AU6219494A (en) 1994-09-26
DE69433422T2 (de) 2004-09-16
US6114143A (en) 2000-09-05
JP3855071B2 (ja) 2006-12-06
ES2213148T3 (es) 2004-08-16

Similar Documents

Publication Publication Date Title
DE69433422D1 (de) Monoklonaler anti-hiv antikörper
PT100195A (pt) Anticorpos monoclonais quimericos e humanos que se ligam a epitopos de receptores de factor de crescimento da epiderme, seus vectores de expressao, processo de preparacao e composicoes farmaceuticas que os contem
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
PT678523E (pt) Anticorpos recombinantes anti-vih e sua preparacao
DK0492560T3 (da) Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider
KR930702509A (ko) 사람 면역결핍 바이러스(hiv)면역치료제
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
ES2059577T3 (es) Fragmentos genicos que codifican para las regiones variables de un anticuerpo anti-hiv, anticuerpos anti-hiv quimericos expresados utilizando los mismos y procedimiento para su preparacion.
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
DK0516135T3 (da) Humant immundefektvirus-relateret immunpræparat
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
EP0511300A1 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
CA2157874A1 (en) Anti-hiv monoclonal antibody
RU2007140569A (ru) Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2
DE69113520D1 (de) Monoklonale Antikörper gegen HIV GP120.
RU2021136626A (ru) АНТИТЕЛО К EphA4
RU2007140570A (ru) Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич
DE68913932D1 (de) Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung.
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
KR20040000401A (ko) Ｈｉｖ 바이러스에 대한 천연 항체
KR960700274A (ko) 재조합 항-hiv 항체 및 그의 제조방법[recombinant anti-hiv antibody and preparation thereof]
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo
RU93004854A (ru) Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека